Video: Osborne Clarke on Arrow declarations

"The disadvantage of going for an Arrow declaration is that you have to put all your cards on the table," says Lorna Brazell of Osborne Clarke.

In this video, Brazell discusses the advantages and challenges of Arrow declarations in the pharmaceutical sector.

Brazell covers different aspects, such as transparency of the process when seeking the declarations and how the court decides on granting them.